An anonymous director reports

CRESCITA THERAPEUTICS ANNOUNCES THE RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

Crescita Therapeutics Inc. has released the voting results from its annual general and special meeting of shareholders held at its corporate headquarters in Laval, Que., on June 20, 2023. The detailed results of the votes received by proxy are provided in attached tables.

Election of directors

Reappointment of external auditor

Consideration of a special resolution approving a change of the municipality of Crescita's registered office

About Crescita Therapeutics Inc.

Crescita is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D (research and development) and manufacturing capabilities. The company offers a portfolio of high-quality, science-based non-prescription skin care products and early-to-commercial-stage prescription products. Crescita also owns multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin.